Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

40.28
+0.68001.72%
Post-market: 40.280.00000.00%19:30 EDT
Volume:487.16K
Turnover:19.60M
Market Cap:2.35B
PE:13.03
High:40.57
Open:39.53
Low:39.51
Close:39.60
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:52.10M
Volume Ratio:0.65
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.35
PE(LYR):14.86

Loading ...

Earnings Flash (HRMY) Harmony Biosciences Posts Q1 EPS $0.55, vs. FactSet Est of $0.69

MT Newswires Live
·
May 07

Harmony Biosciences Q1 revenue rises less than expected

Reuters
·
May 07

Harmony Biosciences Q1 Adj. EPS $0.55 Misses $0.69 Estimate, Sales $215.400M Miss $225.227M Estimate

Benzinga Earnings
·
May 07

BRIEF-Harmony Biosciences Q1 Net Income USD 32.488 Million

Reuters
·
May 07

Harmony Biosciences: on Track to Achieve >$1 Bln in Narcolepsy Net Sales in 2026

THOMSON REUTERS
·
May 07

Harmony Biosciences Q1 Gross Profit USD 170.875 Million

THOMSON REUTERS
·
May 07

Harmony Biosciences Q1 Product Revenue USD 215.387 Million VS. Ibes Estimate USD 225.2 Million

THOMSON REUTERS
·
May 07

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

THOMSON REUTERS
·
May 07

Earning Preview: Harmony Biosciences Holdings, Inc. this quarter’s revenue is expected to increase by 24.26%, and institutional views are predominantly bullish

Earnings Agent
·
Apr 30

Harmony Biosciences to report first-quarter results, host conference call and webcast

Reuters
·
Apr 23

Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed?

Simply Wall St.
·
Apr 22

Harmony Biosciences : Oppenheimer Raises Target Price to $72 From $62

THOMSON REUTERS
·
Apr 22

Harmony Biosciences to present Phase 3 ARGUS extension data for EPX-100 in Dravet syndrome

Reuters
·
Apr 16

Harmony Biosciences reiterates 2026 net product revenue guidance of $1-1.04 billion

Reuters
·
Apr 14

Harmony Biosciences appoints Glenn Reicin as CFO

Reuters
·
Apr 14

Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer

THOMSON REUTERS
·
Apr 14

Harmony Biosciences - Reiterates 2026 Net Product Revenue Guidance of $1.0-$1.04 Bln

THOMSON REUTERS
·
Apr 14

Analysts Offer Insights on Healthcare Companies: ICU Medical (ICUI) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Apr 14